Remove Genetics Remove Genome Project Remove Marketing
article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. The logical extension to this kind of approach is treating individual patients, with their individual genetic makeup.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of blood cancer treatment

pharmaphorum

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2012 – The 100,000 Genomics Project begins. 2016–2022 — New treatments enter the market.

article thumbnail

Expediting innovation in the rare disease domain

pharmaphorum

Collecting data on orphan drugs : Collecting data related to rare diseases and orphan drugs already existing in the market is a time and cost-intensive process. Genetic testing has played a big role in enhancing the diagnosis process. Organizations spend a fortune on building internal teams for collecting this relevant information.

Drugs 78
article thumbnail

Nutrigenomics: The Future of Personalized Nutrition

Roots Analysis

Nutrigenomics is the science studying the relationship between human genome, nutrition and health. In part, the success of the Human Genome Project has also paved a path for the novel concept of nutrigenomics. It is worth mentioning that more than 50 genes in a human body are associated with obesity.

Genome 40
article thumbnail

CRISPR therapies targeting the next breakthrough in oncology

pharmaphorum

Cancer is a genetic disease, caused by certain changes in the way that genes control cell function, such as how they grow and divide. Cancer is a genetic disease, caused by certain changes in the way that genes control cell function, such as how they grow and divide. Why cancer?